Tag: Neutropenia
Physiomics awarded grant for PREDICT-ONC project in precision oncology
Physiomics plc, a leader in mathematical modelling and drug development, announces its latest achievement: securing a grant for the PREDICT-ONC project. This project, funded by ... Read More
Lilly announces promising results for Pirtobrutinib Phase 1/2 trials
Eli Lilly's oncology arm, Loxo@Lilly, disclosed that The New England Journal of Medicine (NEJM) has published an extensive analysis of results from the BRUIN Phase ... Read More
Lupin signs agreement for biosimilar Pegfilgrastim in Brazil
Lupin Limited has signed an exclusive distribution and marketing agreement with Biomm SA for biosimilar Pegfilgrastim in Brazil. The Indian pharma company had earlier secured ... Read More
EC approves Mundipharma’s Neulasta biosimilar Pelmeg for neutropenia
Pelmeg EU approval : The European Commission (EC) has approved German pharma company Mundipharma’s Pelmeg, a pegylated version of granulocyte-colony stimulating factor (G-CSF) and also ... Read More
Nivestym FDA approval : Pfizer’s Amgen neutropenia drug Neupogen biosimilar gets FDA nod
Nivestym FDA approval : Pfizer has bagged approval from the US Food and Drug Administration (FDA) for Nivestym (filgrastim-aafi) – a biosimilar to Neupogen (filgrastim) ... Read More